Sorting out the risks in progressive multifocal leukoencephalopathy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sorting out the risks in progressive multifocal leukoencephalopathy
Authors
Keywords
-
Journal
Nature Reviews Rheumatology
Volume 11, Issue 2, Pages 119-123
Publisher
Springer Nature
Online
2014-10-14
DOI
10.1038/nrrheum.2014.167
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A case of progressive multifocal leukoencephalopathy in a lupus patient treated with belimumab
- (2014) CA Fredericks et al. LUPUS
- JC Virus in CD34+and CD19+Cells in Patients With Multiple Sclerosis Treated With Natalizumab
- (2014) Elliot M. Frohman et al. JAMA Neurology
- JC virus antibody status underestimates infection rates
- (2013) Joseph R. Berger et al. ANNALS OF NEUROLOGY
- Risk factors for rare diseases can be risky to define: PML and natalizumab
- (2013) E. O. Major et al. NEUROLOGY
- PML diagnostic criteria: Consensus statement from the AAN Neuroinfectious Disease Section
- (2013) J. R. Berger et al. NEUROLOGY
- JC Viremia in Natalizumab-Treated Patients with Multiple Sclerosis
- (2013) Eugene O. Major et al. NEW ENGLAND JOURNAL OF MEDICINE
- Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: Evolving role of biologic therapies
- (2012) Eamonn S. Molloy et al. ARTHRITIS AND RHEUMATISM
- Drug-Induced PML: A Global Agenda for a Global Challenge
- (2012) M Vinhas de Souza et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Goal-Oriented Patient Care — An Alternative Health Outcomes Paradigm
- (2012) David B. Reuben et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
- (2011) David B. Clifford ARCHIVES OF NEUROLOGY
- PML and rheumatology: The contribution of disease and drugs
- (2011) E. S. MOLLOY CLEVELAND CLINIC JOURNAL OF MEDICINE
- The basis for modeling progressive multifocal leukoencephalopathy pathogenesis
- (2011) Joseph R Berger CURRENT OPINION IN NEUROLOGY
- Anti-JC virus antibodies: Implications for PML Risk Stratification
- (2010) Leonid Gorelik et al. ANNALS OF NEUROLOGY
- Progressive multifocal leukoencephalopathy: A national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases
- (2009) Eamonn S. Molloy et al. ARTHRITIS AND RHEUMATISM
- Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors
- (2009) Adrian Egli et al. JOURNAL OF INFECTIOUS DISEASES
- Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression
- (2009) S. Gheuens et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Targeted but not trouble-free: efalizumab and PML
- (2009) Eamonn S. Molloy et al. Nature Reviews Rheumatology
- Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab
- (2009) Yiping Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies
- (2008) L. H. Calabrese et al. ANNALS OF THE RHEUMATIC DISEASES
- Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: Are patients with systemic lupus erythematosus at particular risk?
- (2008) Eamonn S. Molloy et al. AUTOIMMUNITY REVIEWS
- The bone marrow, B cells, and JC virus
- (2008) Sidney A Houff et al. JOURNAL OF NEUROVIROLOGY
- Progressive Multifocal Leukoencephalopathy and Use of Mycophenolate Mofetil After Kidney Transplantation
- (2008) Robert T. Neff et al. TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation